Pricing in Germany: How is the reimbursed price of a drug set?
At the time of launch in the German market, pharmaceutical companies are free to set the price for their product with a
Tag: AMNOG process
First COVID-19 drug has been assessed by G-BA
The antiviral drug remdesivir (brand name: Veklury) has been the first drug targeting COVID-19, which has undergone an early benefit assessment. It
What is reference pricing?
If the G-BA concludes its early benefit assessment with “No additional benefit (proven)” and the product falls into a reference price group,
Negotiated reimbursement price applicable 12 months after launch
The early benefit assessment – 7 new laws since AMNOG
Since 2011, 7 new laws were added to AMNOG to dictate the early benefit assessment of drugs. Therefore, it is often called